CANTON STRATEGIC HOLDINGS IN (CNTN) Fundamental Analysis & Valuation

NASDAQ:CNTN • US4327053090

Current stock price

3.495 USD
-0.08 (-2.37%)
Last:

This CNTN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CNTN Profitability Analysis

1.1 Basic Checks

  • CNTN had negative earnings in the past year.
  • In the past year CNTN has reported a negative cash flow from operations.
  • CNTN had negative earnings in each of the past 5 years.
  • In the past 5 years CNTN always reported negative operating cash flow.
CNTN Yearly Net Income VS EBIT VS OCF VS FCFCNTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • CNTN has a Return On Assets of -6.92%. This is amongst the best in the industry. CNTN outperforms 83.53% of its industry peers.
  • CNTN's Return On Equity of -9.03% is amongst the best of the industry. CNTN outperforms 86.43% of its industry peers.
Industry RankSector Rank
ROA -6.92%
ROE -9.03%
ROIC N/A
ROA(3y)-139.94%
ROA(5y)-180.25%
ROE(3y)-347.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTN Yearly ROA, ROE, ROICCNTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • CNTN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNTN Yearly Profit, Operating, Gross MarginsCNTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

8

2. CNTN Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CNTN has more shares outstanding
  • Compared to 5 years ago, CNTN has more shares outstanding
  • CNTN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNTN Yearly Shares OutstandingCNTN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CNTN Yearly Total Debt VS Total AssetsCNTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • CNTN has an Altman-Z score of 1.87. This is not the best score and indicates that CNTN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CNTN's Altman-Z score of 1.87 is fine compared to the rest of the industry. CNTN outperforms 64.15% of its industry peers.
  • There is no outstanding debt for CNTN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.87
ROIC/WACCN/A
WACCN/A
CNTN Yearly LT Debt VS Equity VS FCFCNTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • CNTN has a Current Ratio of 157.97. This indicates that CNTN is financially healthy and has no problem in meeting its short term obligations.
  • CNTN's Current ratio of 157.97 is amongst the best of the industry. CNTN outperforms 100.00% of its industry peers.
  • A Quick Ratio of 157.97 indicates that CNTN has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 157.97, CNTN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 157.97
Quick Ratio 157.97
CNTN Yearly Current Assets VS Current LiabilitesCNTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

0

3. CNTN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 70.80% over the past year.
EPS 1Y (TTM)70.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.01%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNTN Yearly EPS VS EstimatesCNTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

0

4. CNTN Valuation Analysis

4.1 Price/Earnings Ratio

  • CNTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CNTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTN Price Earnings VS Forward Price EarningsCNTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTN Per share dataCNTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CNTN Dividend Analysis

5.1 Amount

  • No dividends for CNTN!.
Industry RankSector Rank
Dividend Yield 0%

CNTN Fundamentals: All Metrics, Ratios and Statistics

CANTON STRATEGIC HOLDINGS IN

NASDAQ:CNTN (4/16/2026, 12:04:46 PM)

3.495

-0.08 (-2.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)N/A
Inst Owners14.25%
Inst Owner Change0%
Ins Owners0.3%
Ins Owner ChangeN/A
Market Cap198.03M
Revenue(TTM)N/A
Net Income(TTM)-35.92M
Analysts82.86
Price TargetN/A
Short Float %6.18%
Short Ratio5.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.5
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-2.89
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-1.65
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0
BVpS7.02
TBVpS7.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.92%
ROE -9.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-139.94%
ROA(5y)-180.25%
ROE(3y)-347.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 157.97
Quick Ratio 157.97
Altman-Z 1.87
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.1%
EPS Next Y99.01%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-759.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.94%
OCF growth 3YN/A
OCF growth 5YN/A

CANTON STRATEGIC HOLDINGS IN / CNTN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CANTON STRATEGIC HOLDINGS IN (CNTN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CNTN.


What is the valuation status of CANTON STRATEGIC HOLDINGS IN (CNTN) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANTON STRATEGIC HOLDINGS IN (CNTN). This can be considered as Overvalued.


What is the profitability of CNTN stock?

CANTON STRATEGIC HOLDINGS IN (CNTN) has a profitability rating of 2 / 10.


What is the financial health of CANTON STRATEGIC HOLDINGS IN (CNTN) stock?

The financial health rating of CANTON STRATEGIC HOLDINGS IN (CNTN) is 8 / 10.


Can you provide the expected EPS growth for CNTN stock?

The Earnings per Share (EPS) of CANTON STRATEGIC HOLDINGS IN (CNTN) is expected to grow by 99.01% in the next year.